Influenza
Everything NICE has said on influenza in an interactive flowchart
Search results
537 results
-
-
Gastrointestinal cancers
Everything NICE has said on gastrointestinal cancers in an interactive flowchart
-
Gallstone disease
Everything NICE has said on diagnosing and managing gallstone disease in adults in an interactive flowchart
-
Glaucoma
Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart
-
Generalised anxiety disorder
Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart
-
Harmful sexual behaviour among children and young people
Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.
-
Hearing loss
Everything NICE has said on hearing loss or impairment in adults in an interactive flowchart
-
Type 2 diabetes in adults
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
-
Blood and immune system conditions
Everything NICE has said on blood and immune system conditions in an interactive flowchart
-
Liver cancers
Everything NICE has said on liver and bile duct cancers in an interactive flowchart
-
Pancreatitis
Everything NICE has said on pancreatitis in an interactive flowchart
-
Eating disorders
Everything NICE has said on identifying and managing eating disorders in people 8 years and over in an interactive flowchart
-
Antenatal care for uncomplicated pregnancies
Everything NICE has said on antenatal care for healthy women with uncomplicated pregnancies in an interactive flowchart
-
Bedwetting in children and young people
Everything NICE has said on assessing and managing bedwetting (nocturnal enuresis) in children and young people under 19 in an interactive flowchart
-
Diabetes in children and young people
Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart
-
Type 1 diabetes in adults
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
-
Diabetes in pregnancy
Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart
-
Smoking
Everything NICE has said on preventing the uptake of smoking and helping people to stop smoking in an interactive flowchart
-
Acutely ill patients in hospital
Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart
-
Urogenital conditions
Everything NICE has said on urogenital conditions in an interactive flowchart
-
Urinary incontinence in neurological disease
Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart
-
Vitamin D: supplement use in specific population groups
Everything NICE has said on preventing vitamin D deficiency in specific population groups in an interactive flowchart
-
Rheumatoid arthritis
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
-
Early and locally advanced breast cancer
Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart
-
Intrapartum care for women with obstetric complications
Everything NICE has said on intrapartum care for women with obstetric complications in an interactive flowchart
-
Sepsis
Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart
-
Colorectal cancer
Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart
-
Lower urinary tract symptoms in men
Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart
-
Neurological conditions
Everything NICE has said on neurological conditions in an interactive flowchart
-
Cystic fibrosis
Everything NICE has said on diagnosing and managing cystic fibrosis in an interactive flowchart
-
myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
NICE has developed a medtech innovation briefing (MIB) on myCOPD for self-management of chronic obstructive pulmonary disease
-
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
-
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
-
Antimicrobial prescribing: cefiderocol (ES31)
Summary of the evidence on antimicrobial prescribing: cefiderocol
-
Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)
Summary of the evidence on antimicrobial prescribing: delafloxacin
-
COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 (ES24)
ES24 . Key messages The content of this evidence review was up-to-date
-
COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES25)
ES25 . Key messages The content of this evidence review was up-to-date on 20 April 2020. See summaries of product characteristics
-
COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis (ES26)
ES26 . Key messages The content of this evidence review was up-to-date on 13 May 2020. See summaries of product characteristics
-
COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES23)
ES23 . Key messages The content of this evidence review was up-to-date
-
COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)
ES27 . Key messages The content of this evidence review was up-to-date on 4 June 2020. See summaries of product characteristics
-
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
-
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MIB210)
NICE has developed a medtech innovation briefing (MIB) on TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation
-
Archimedes for biopsy of suspected lung cancer (MIB211)
NICE has developed a medtech innovation briefing (MIB) on Archimedes for biopsy of suspected lung cancer
-
MolecuLight i:X for wound imaging (MIB212)
NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging
-
Lifelight First for monitoring vital signs (MIB213)
NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs
-
Space from Depression for treating adults with depression (MIB215)
NICE has developed an Improving Access to Psychological Therapies (IAPT) report on Space from Depression for treating adults with depression
-
FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216)
NICE has developed a medtech innovation briefing (MIB) on FibroScan for assessing liver fibrosis and cirrhosis in primary care
-
Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)
NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19
-
Artificial intelligence for analysing CT brain scans (MIB207)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans
-
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wound